2nd Quarter - Report

TIBER CREEK GROUP for VERTEX PHARMACEUTICALS

Firm
Client
Income
$60,000
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Issues related to drug pricing; Issues related to H.R. 1227/S. 475 - Alternatives to PAIN Act; Issues related to H.R. 1518 - New Era of Preventing End-Stage Kidney Disease Act.

LobbyistCovered position, as disclosed
JONATHON JONES —
EMILY KIRLIN —
DANIEL HOWARD ZAWITOSKI —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 1227 (119th), S. 475 (119th), H.R. 1518 (119th)

Defense DEF

Issues related to coverage of opioid alternatives.

LobbyistCovered position, as disclosed
JONATHON JONES —
EMILY KIRLIN —
DANIEL HOWARD ZAWITOSKI —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.